Tag Archives: Eric Winer

Genomic Studies Reveal a Tumor’s Secrets

By Robert Levy
One day, the genome of a tumor will be as revealing as a tell-all memoir. Doctors will obtain a full report on each tumor’s genomic quirks – its vulnerabilities, defenses, survival strategies, even its history of advance and retreat. The revelations will help physicians decide which therapies, in which order and at what doses, are most likely to work.
At Dana-Farber and other centers around the world, the effort to understand tumors at such an intimate  level is well under way. Advances in DNA sequencing are enabling scientists to catalog the full extent of genomic abnormalities in many types …

 

Hitching a Ride

Will an emerging cancer therapy that links potent drugs to tumor-seekers take the place of standard chemotherapy?
by Elizabeth Dougherty

Eric Winer, MD (left), has been leading clinical trials at DF/BWCC focusing on the antibody-drug conjugate T-DM1.

Sarah Merchant was working as a Web designer in Boston when, at age 28, she was diagnosed with stage 4 metastatic breast cancer. Surgery, radiation, and a series of chemotherapy regimens followed, as did nerve damage, hair loss, and a general decline in her health.
Then Merchant heard about T-DM1, a trial drug promising the effectiveness of chemotherapy without the toxicity. “I wanted to get into that …

 

Dana-Farber physicians recognized as ‘Top Doctors’ in Boston area

Thirty-one Dana-Farber Cancer Institute cancer specialists were recognized by Boston magazine for being among the area’s top physicians.
Published in the December 2010 issue of Boston magazine, the “Top Doctors” list consists of 598 Boston-area physicians from 55 medical specialties who were included in Castle Connolly’s America’s Top Doctors survey.

Tags: Boston, Boston Magazine, Castle Connolly Medical LTD, dana farber, Dirk Iglehart, Eric Winer, Featured, Harold Burstein, Jay Harris, Judy Garber, Lawrence Shulman, Lee Nadler, MD, Philip Kantoff, top doctors

 

Dana-Farber physicians recognized as 'Top Doctors' in Boston area

Thirty-one Dana-Farber Cancer Institute cancer specialists were recognized by Boston magazine for being among the area’s top physicians.
Published in the December 2010 issue of Boston magazine, the “Top Doctors” list consists of 598 Boston-area physicians from 55 medical specialties who were included in Castle Connolly’s America’s Top Doctors survey.

Tags: Boston, Boston Magazine, Castle Connolly Medical LTD, dana farber, Dirk Iglehart, Eric Winer, Featured, Harold Burstein, Jay Harris, Judy Garber, Lawrence Shulman, Lee Nadler, MD, Philip Kantoff, top doctors

 

Breast cancer patients benefit from telephone-monitored exercise

Home-based activity program can prevent treatment-related weight gain
Getting more exercise may be the last thing a breast cancer patient feels like doing while undergoing the rigors of chemotherapy and radiation. However, new research by scientists in the Susan F. Smith Center for Women’s Cancers has found that weekly phone consultations enabled patients to step up their physical activity, improve their quality of life, and prevent weight gain that often occurs during breast cancer treatment.
Jennifer Ligibel, MD, and colleagues are studying the impact of exercise in breast cancer patients with the eventual …

 

Yawkey Center strengthens ties between cancer care and research

Bridges connect the Yawkey Center’s patient-care areas (right) with research labs (left)
When a moving van pulls up to the curb of a new home, it often marks the beginning of a family’s next stage of growth.
For the Dana-Farber family, that moving van arrives this winter, when many clinical operations move to the new Yawkey Center for Cancer Care, signaling the next phase in the Institute’s 63-year battle against cancer.
The Yawkey Center, opening in February 2011, will create stronger links between patient care and research, with treatment areas organized by disease type and focused …

 

Genes found linked to breast cancer drug resistance could guide future treatment choices

Andrea Richardson, MD, PhD, and Zhigang Charles Wang, MD, PhD
Researchers at Dana-Farber Cancer Institute have discovered a gene activity signature that predicts a high risk of cancer recurrence in certain breast tumors that have been treated with commonly used chemotherapy drugs.
Despite their resistance to drugs of the anthracycline class, the breast cancers bearing this gene signature will probably still be vulnerable to other types of chemotherapy agents, say scientists in a letter to be published in Nature Medicine on its Web site and later in a print edition.

Tags: Andrea Richardson, Breast Cancer, Breast Cancer Research Foundation of New York, dana …

 

Karen Webster Cancer tests your mettle, management consultant discovers

After receiving her diagnosis and undergoing a lumpectomy near her home in Maryland, breast cancer survivor and management consultant Karen Webster searched the Internet to find the right cancer center and oncologist for her follow-up care. She wanted more than a traditional approach and settled on Dana-Farber/Brigham and Women’s Cancer Center and its breast cancer specialist Eric Winer, MD — 750 miles away.
“Something about his write-up appealed to me,” recalls Webster. “In addition to offering the very best treatments, he also seemed focused on quality of life. I knew immediately that he was my …

 

A focus on breast cancer in young women by Elaine Gottlieb

Carie Capossela, here with her two children, was diagnosed with breast cancer in 2001 at age 33.

By and large, breast cancer is not thought of as a young woman’s disease. After all, 95 percent of women with breast cancer are over age 40.
But every year, 10,000 women age 40 and younger in the U.S. alone learn that breast cancer can and does affect women their age, and it brings with it an additional layer of challenges.

Tags: Ann Partridge, Breast Cancer, Breast Oncology Center, Carie Capossela, Dana-Farber's Women's Cancers Programs, Eric Winer, Kathyrn Ruddy, Lance Armstrong …